|
And-1 Inhibition by DHS for Cancer Treatment
GW researchers developed DHS (4,4’-trans-dihydroxystilbene) as a new cytotoxic anticancer drug for use alone or in combination with other chemotherapies. Drug toxicity and drug resistance limit the ability of many cytotoxic cancer drugs to effectively treat cancer, a problem which is overcome by DHS. The cancer killing efficacy of DHS is...
Published: 1/7/2022
|
Updated: 10/26/2021
|
Inventor(s): Chi-Wei Chen, Zhiyong Han, Wenge Zhu, Yongming Li
Keywords(s):
Category(s): Technology Classifications > Therapeutics > Small Molecules
|
